The Ohio State University
Targeted Therapies Drive the Global Renal Cell Carcinoma (RCC) Drugs Market ...San Francisco Chronicle (press release)The global market for Renal Cell Carcinoma (RCC) Drugs is forecast to reach $3.03 billion by the year 2017, driven by the growing preference for targeted therapies in the treatment of RCC. Additionally, growth is also expected to stem from the ...
